Zolpidem and Hydrocortisone sodium succinate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Zolpidem (zolpidem tartrate) and Hydrocortisone sodium succinate (hydrocortisone sodium succinate). Common drug interactions include pyrexia among females and pyrexia among males.

The phase IV clinical study analyzes what interactions people have when they take Zolpidem and Hydrocortisone sodium succinate. It is created by eHealthMe based on reports of 92 people who take the same drugs from the FDA, and is updated regularly.

What is Zolpidem?

Zolpidem has active ingredients of zolpidem tartrate. It is often used in insomnia. eHealthMe is studying from 92,695 Zolpidem users. Check the latest studies of Zolpidem.

What is Hydrocortisone sodium succinate?

Hydrocortisone sodium succinate has active ingredients of hydrocortisone sodium succinate. eHealthMe is studying from 3,777 Hydrocortisone sodium succinate users. Check the latest studies of Hydrocortisone sodium succinate.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 20, 2026

92 people who take Zolpidem and Hydrocortisone sodium succinate together, and have interactions are studied.

Zolpidem and Hydrocortisone sodium succinate drug interactions.

What are the common drug interactions of Zolpidem and Hydrocortisone Sodium Succinate, by gender? *:

female:

  1. Pyrexia (fever)
  2. Acute myeloid leukaemia recurrent (acute cancer in which the bone marrow makes abnormal myeloblast- recurrent)
  3. Headache (pain in head)
  4. Oral disorder (mouth disease)
  5. Hyperglycaemia (high blood sugar)
  6. Liver disorder (liver diseases)
  7. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  8. Thrombocytopenia (decrease of platelets in blood)
  9. Venoocclusive liver disease (small veins in the liver are obstructed)
  10. Acute graft versus host disease in liver (acute complication in liver following an allogeneic tissue/blood transplant)

male:

  1. Pyrexia (fever)
  2. Nausea (feeling of having an urge to vomit)
  3. Diarrhoea
  4. Hypokalaemia (low potassium)
  5. Acute graft versus host disease in liver (acute complication in liver following an allogeneic tissue/blood transplant)
  6. Acute myeloid leukaemia recurrent (acute cancer in which the bone marrow makes abnormal myeloblast- recurrent)
  7. Anaemia (lack of blood)
  8. Body temperature increased
  9. Cellulitis (infection under the skin)
  10. Graft versus host disease in skin (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the skin)

What are the common drug interactions of Zolpidem and Hydrocortisone Sodium Succinate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Infection
  2. Pneumonia cytomegaloviral (cmv pneumonia is caused by a member of a group of herpes-type viruses)
  3. Renal failure acute (rapid kidney dysfunction)
  4. Transplant rejection (a transplant material is not worked)

20-29:

  1. Liver disorder (liver diseases)
  2. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  3. Hepatic failure (liver failure)
  4. Septic shock (shock due to blood infection)
  5. Acute graft versus host disease in liver (acute complication in liver following an allogeneic tissue/blood transplant)
  6. Acute graft versus host disease in skin (acute complication on skin following an allogeneic tissue/blood transplant)
  7. Altered state of consciousness (altered state of mind)
  8. Anaphylactoid reaction (type of anaphylaxis that does not involve an allergic reaction but is due to direct mast cell degranulation)
  9. Blood lactate dehydrogenase increased
  10. Cardiac tamponade (fluid accumulates in heart covering)

30-39:

  1. Pyrexia (fever)
  2. Acute graft versus host disease in skin (acute complication on skin following an allogeneic tissue/blood transplant)
  3. Acute myeloid leukaemia recurrent (acute cancer in which the bone marrow makes abnormal myeloblast- recurrent)
  4. Headache (pain in head)
  5. Neuropathy peripheral (surface nerve damage)
  6. Oral disorder (mouth disease)
  7. Pruritus (severe itching of the skin)
  8. Oedema (fluid collection in tissue)
  9. Toothache (tooth pain)
  10. Diarrhoea

40-49:

  1. Blood bilirubin increased
  2. Weight increased
  3. Pyrexia (fever)
  4. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  5. Abnormal behaviour
  6. Acute graft versus host disease in liver (acute complication in liver following an allogeneic tissue/blood transplant)
  7. Acute graft versus host disease in skin (acute complication on skin following an allogeneic tissue/blood transplant)
  8. Antithrombin iii decreased
  9. Cytomegalovirus test positive
  10. Disease recurrence

50-59:

  1. Constipation
  2. Cough
  3. Diarrhoea
  4. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  5. Hypocalcaemia (levels of calcium in blood serum are abnormally low)
  6. Hypokalaemia (low potassium)
  7. Infection
  8. Pyrexia (fever)
  9. Rash
  10. Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node)

60+:

  1. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  2. Thrombocytopenia (decrease of platelets in blood)
  3. Hypokalaemia (low potassium)
  4. Nausea (feeling of having an urge to vomit)
  5. Renal failure acute (rapid kidney dysfunction)
  6. Subdural haematoma (blood collects between the skull and the surface of the brain)
  7. Tumour lysis syndrome (a group of metabolic complications that can occur after treatment of cancer, these complications are caused by the breakdown products of dying cancer cells)
  8. Vomiting
  9. Dyspnoea (difficult or laboured respiration)
  10. Dementia (madness)

What are the existing conditions these people have? *

  1. High Blood Pressure: 24 people, 26.09%
  2. Constipation: 20 people, 21.74%
  3. Fever: 17 people, 18.48%
  4. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 16 people, 17.39%
  5. Bone Marrow Conditioning Regimen: 12 people, 13.04%
  6. Hypokalemia (low potassium): 12 people, 13.04%
  7. Aplastic Anemia: 10 people, 10.87%
  8. Multiple Myeloma (cancer of the plasma cells): 10 people, 10.87%
  9. Infection: 10 people, 10.87%
  10. Diarrhea: 9 people, 9.78%

* Approximation only. Some reports may have incomplete information.

Do you take Zolpidem and Hydrocortisone sodium succinate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Zolpidem and Hydrocortisone sodium succinate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Zolpidem:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Hydrocortisone sodium succinate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zolpidem and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Hydrocortisone sodium succinate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on zolpidem tartrate and hydrocortisone sodium succinate (the active ingredients of Zolpidem and Hydrocortisone sodium succinate, respectively), and Zolpidem and Hydrocortisone sodium succinate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: